Sorrento Therapeutics PE Ratio Trends

Sorrento Therapeutics Inc (SRNE)

0.024 0.00 (0.00%) USD | OTCM | Apr 18, 15:52

PE Ratio Chart

Historical PE Ratio Data

View and export this data back to 2009. Upgrade now.

Date	Value
June 29, 2018	65.45
June 28, 2018	65.45
June 27, 2018	61.82
June 26, 2018	64.55
June 25, 2018	57.73
June 22, 2018	59.55
June 21, 2018	55.91
June 20, 2018	60.45
June 19, 2018	63.64
June 18, 2018	66.36
June 15, 2018	67.27
June 14, 2018	66.82
June 13, 2018	67.73
June 12, 2018	65.91
June 11, 2018	65.00
June 08, 2018	67.73
June 07, 2018	65.91
June 06, 2018	67.27
June 05, 2018	67.50
June 04, 2018	67.73
June 01, 2018	69.55
May 31, 2018	71.36
May 30, 2018	72.73
May 29, 2018	71.82
May 25, 2018	71.36

Date	Value
May 24, 2018	72.27
May 23, 2018	68.64
May 22, 2018	65.91
May 21, 2018	65.45
May 18, 2018	65.45
May 17, 2018	65.45
May 16, 2018	67.27
May 15, 2018	66.36
May 14, 2018	68.18
May 11, 2018	69.09
May 10, 2018	66.82
May 09, 2018	68.64
May 08, 2018	63.18
May 07, 2018	65.00
May 04, 2018	58.64
May 03, 2018	57.73
May 02, 2018	58.64
May 01, 2018	57.50
April 30, 2018	55.91
April 27, 2018	57.27
April 26, 2018	56.82
April 25, 2018	55.45
April 24, 2018	55.00
April 23, 2018	55.45
April 20, 2018	57.27

Price to Earnings Ratio (PE Ratio) Definition

The Price to Earnings Ratio (PE Ratio) is calculated by taking the stock price / EPS Diluted (TTM). This metric is considered a valuation metric that confirms whether the earnings of a company justifies the stock price. There isn't necesarily an optimum PE ratio, since different industries will have different ranges of PE Ratios. Because of this, PE Ratio is great to evaluate from a relative standpoint with other similar companies.

Read full definition.

PE Ratio Range, Past 5 Years

Minimum

Maximum

Average

Median

PE Ratio Benchmarks

Scilex Holding Co	--
AIM ImmunoTech Inc	--
Perspective Therapeutics Inc	--
Protalix BioTherapeutics Inc	56.25
Armata Pharmaceuticals Inc	--

PE Ratio Related Metrics

Price	0.024
Market Cap	13.23M